Cellectar Biosciences, Inc. (CLRB) vs Tempest Therapeutics, Inc. (TPST)
A side-by-side comparison of Cellectar Biosciences, Inc. and Tempest Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLRB
Cellectar Biosciences, Inc.
$1.55HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
TPST
Tempest Therapeutics, Inc.
$0.78HealthcareDelayed quote: Oct 6, 2026, 2:57 PM EDT
Total return — CLRB vs TPST
growth of $100 · dividends reinvested · last 10yCLRB -100.0% (-55.5%/yr)TPST -100.0% (-64.0%/yr)CLRB compounded faster over this window
Log scale — wide-divergence pair
CLRB TPST
CLRB vs TPST: by the numbers
- •TPST is the larger company ($12M vs $12M market cap).
Metrics side by side
Valuation
| Metric | CLRB | TPST |
|---|---|---|
| P/B ratio | 0.41 | N/A |
Profitability
| Metric | CLRB | TPST |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -74.73% | N/A |
| ROIC | -74.94% | -784.16% |
Growth (annualized)
| Metric | CLRB | TPST |
|---|---|---|
| Total return CAGR (5Y) | -60.51% | -66.75% |
Frequently asked
- How have CLRB and TPST total returns compared?
- Over the past 10 years, CLRB delivered -55.35% and TPST delivered -64.11% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.